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When a replicative DNA polymerase stalls upon encountering a lesion on the template strand, it is relieved by other low-
processivity polymerase(s), which insert nucleotide(s) opposite the lesion, extend by a few nucleotides, and dissociate from the
3 -OH. The replicative polymerase then resumes DNA synthesis. This process, termed translesion replication (TLS) or replicative
bypass,mayinvolveatleastﬁvediﬀerentpolymerasesinmammals,althoughtheparticipatingpolymerasesandtheirroleshavenot
been entirely characterized. Using siRNAs originally designed and an alkaline sucrose density gradient sedimentation technique,
we veriﬁed the involvement of several polymerases in ultraviolet (UV) light-induced TLS in HeLa cells. First, siRNAs to Rev3 or
Rev7 largely abolished UV-TLS, suggesting that these 2 gene products, which comprise Polζ, play a main role in mutagenic TLS.
Second, Rev1-targeted siRNA also abrogated UV-TLS, indicating that Rev1 is also indispensable to mutagenic TLS. Third, Polη-
targeted siRNA also prevented TLS to a greater extent than our expectations. Forth, although siRNA to Polι had no detectable
eﬀect, that to Polκ delayed UV-TLS. To our knowledge, this is the ﬁrst study reporting apparent evidence for the participation of
Polκ in UV-TLS.
1.Introduction
Multiple systems have evolved to manage the genomic
photoproducts generated by harmful UV light. One such
system is nucleotide excision repair (NER), which eliminates
photoproducts from DNA strands by dual incision on both
sides of a damaged base. The NER system cannot, however,
removeallUV-damagedbases.WhenareplicativeDNApoly-
merase stalls upon encountering a residual photoproduct on
the template strand, it is relieved by other low-processivity
polymerase(s), which incorporate nucleotide(s) opposite the
lesion, extend by a few nucleotides and dissociate from
the 3 -OH. The replicative polymerase then resumes DNA
synthesis. This process, termed translesion replication (TLS)
or replicative bypass (reviewed in [1]), is also one of the
subtle systems that have evolved for the management of
genomic photoproducts.
UV-C (100–290nm wavelength) induces 2 main pho-
toproducts [2]: the more frequent cyclobutane pyrimi-
dine dimer (CPD) and the several-fold lower pyrimidine-
pyrimidone (6-4) photoproduct ((6-4)PP). cis-syn CPD, a
predominant form of the multiple conﬁgurations, contains
2 adjacent pyrimidines that are covalently linked in parallel.
Although the frequency of CPD varies with nucleotide com-
position, a ratio of T-T to C-T to T-C to C-C of 68:13:16:3
is obtained from UV-irradiated plasmid DNA. Cytosines
within CPD are unstable, and are deaminated to uracil or 5-
methylcytosine, and further deaminated to thymine [3]. The
helical distortion caused by CPD is so inconspicuous that
almost half of the lesions remain unrepaired by NER, even
6 hours after UV irradiation in the case of CHO cells [2].
The (6-4)PPs from T-C, C-C, and, less frequently, T-T
sequences are detected in UV-irradiated DNA whereas that
of C-T are not. In (6-4)PP, linkage between C-6 of one
pyrimidine and C-4 of the adjacent pyrimidine cause the 2
bases to be in nearly perpendicular position. Consequently,
formation of this lesion causes a major distortion in the
double helix. NER preferentially removes (6-4)PP more2 Journal of Nucleic Acids
rapidly thanit removes CPD fromthe genomein humanand
rodent cells [4].
At least 5 mammalian DNA polymerases are suggested to
be implicated in UV-induced TLS: Pols η, ι, ζ, κ,a n dR e v 1 ,
all of which belong to the Y family except for Polζ (B family)
(reviewed in [1, 5, 6]). However, the participating poly-
merases and their roles have not been entirely characterized.
Patients with the autosomal recessive disorder, xero-
derma pigmentosum variant (XP-V), have a predisposition
to skin cancer, and XP-V cells demonstrate hypermutability
after UV irradiation (reviewed in [7]). The defective gene in
XP-V encodes Polη, which was ﬁrst puriﬁed from a HeLa cell
extract as an activity that complements TLS defect in XP-V
cell extract [8]. Human Polη catalysed DNA synthesis past
TT-CPD very eﬃciently and in a relatively accurate manner,
as demonstrated by the lesion-bypass assay [7, 9]. When
template DNA contained a (6-4)TT-PP, Polη incorporated
one (random) nucleotide opposite the ﬁrst thymine and
another nucleotide opposite the second thymine of the
lesion, but rarely continued across the lesion [7, 9].
Human Polη was also identiﬁed via a search for the
homologofyeastSaccharomycescerevisiaeRad30gene,which
e n c o d e sa ne r r o r - f r e eb y p a s sp r o t e i n[ 10]. Various XP-V
causative mutations have been found in the Polη gene,
hRAD30A, of XP-V patients [10, 11].
Polι (RAD30B) is the other mammalian homolog of
yeast Polη, isolated by a similar approach [12]. In contrast to
Polη,P o l ι is less eﬃcient and less accurate [13].
Polκ was obtained by cloning of a human homolog of
the E. coli dinB gene, encoding DNA Pol IV [14]. Polκ was
reported to be unable to bypass either CPD or (6-4)PP
[15, 16].
Originally, Rev1, 3, and 7 were cloned from S. cerevisiae
isolates, in which the frequency of UV-induced reversion
from cyc1 mutations was reduced [17]. Human and mouse
homologs (Rev1, 3, 7 gene) were later isolated [18–20]. Polζ
is a comprex of the Rev3 and Rev7 gene products, which
act as the catalytic and regulatory subunit, respectively. Yeast
Polζ is shown to be responsible for 98% of UV-induced base
substitutions and 90% of frameshift mutations, in addition
to spontaneous mutations [21]. Nonetheless, yeast Polζ itself
was revealed to be too faithful to incorporate opposite
CPD. Instead, it can eﬃciently extend from a matched or
mismatched 3 -end (reviewed in [5, 6]). Human or mouse
Polζ is assumed to have similar enzymatic properties to that
of yeast, because several lines of antisense RNA expression
or siRNA knockdown experiments in human or mouse cells
have proven that Polζ is involved in mutagenic TLS [22–24].
Yeast and human Rev1 encode highly specialized DNA
polymerases that preferentially insert a C residue opposite an
abasicsiteinthetemplate.Thisdeoxycytidyl(dC)transferase
activity is, however, unlikely to be required for UV-TLS,
judging by observation in a yeast rev1-1 mutant strain [25],
which retains much of its dC transferase activity, but has
a missense mutation (G193R) in the N-terminal BRCT
domain.Rev1proteinalsocontainsubiquitin-bindingmotifs
(UBMs) that interact with monoubiquitinated PCNA (a
DNA polymerase sliding clamp) [26]. In the downstream C-
terminal region, Rev1 interacts not only with Rev7 but also
with other bypass-polymerases [27], suggesting that Rev1
acts as a mediator and physical bridges between PCNA and
Polζ.
Following DNA damage, such as that caused by UV and
MMS, monoubiquitins are conjugated to PCNA arrested
at the lesion-site by RAD6/RAD18 and recruit bypass-
polymerases [28, 29]. In addition to Rev1, Pols η, ι,a n dκ
possess UBMs and physically interact with PCNA [1, 5, 6].
Stalled replicative Polδ is replaced, in turn, with one of these
bypass polymerases bound on the PCNA by yet unknown
“polymerase switching” mechanisms (reviewed in [1, 30]).
Translesion replication is typically detected with an alka-
line sucrose density gradient centrifugation (ASDG) tech-
nique. Pulse-labelled replication products are smaller in UV-
irradiated XP-V cells than in unirradiated cells; however, on
prolonged incubation, the replication products in the irradi-
ated cells eventually attain a high molecular weight similar to
that in unirradiated cells. This conversion is interpreted that
DNA synthesis is temporarily retarded by UV photoprod-
ucts,andthencontinuesbeyondthelesion,leavingagapthat
is subsequently sealed [31]. The initial size of the newly syn-
thesized DNA is approximately equal to the average distance
between lesions in the template strands [32]. This means the
gaps in the newly synthesized DNA are opposite the photo-
products [33]. Therefore, sealing of the gaps, by translesion
or other postreplication repair mechanisms, can be observed
by monitoring the molecular weight of labelled DNA.
Using a modiﬁed ASDG technique [34], we precisely
detected the elongation of pulse-labelled replication
products in the irradiated XP-V cells, showing that UV-TLS
is delayed in the cells, but not completely abolished [35].
The marginal TLS is markedly prevented by caﬀeine at
millimolar concentrations, as Lehmann et al. pointed out
[31], and by proteasome inhibitors as well (unpublished
results). In contrast, these agents do not retard UV-TLS in
normal diploid cells. To know more about the ineﬃcient
polymerase(s) in vivo, we added speciﬁc DNA polymerase
inhibitors. Butylphenyldeoxyguanosine (BuPGdR) inhibited
TLS in XP-V cells [35], suggesting that Polζ may be involved
in this Polη-independent bypass.
We recently reported that caﬀeine or proteasome
inhibitors inhibit UV-TLS also in human cancer cells [36],
and that, similar to XP-V cells, UV-TLS was much slower
than in normal cells. These results suggested that UV bypass
in cancer cells is predominantly of the Polη-independent
type. Therefore, we expected that Polζ plays a major part
in UV-TLS in cancer cells. Although Polη exists in normal
quantity in these cells, it was supposed to be inactivated by
some reasons. We explored these hypotheses here.
2.MaterialsandMethods
2.1. Design of siRNAs. All siRNAs duplexes were synthesized
by JBioS (Japan) (Table 1). We designed the sequences for
siRNA according to the JBioS guide (http://www.JBioS.co
.jp/RNAiselect.htm). Selection of target sequence for each
siRNA proceeds as follows: ﬁrst, an AAG or AAC sequence is
found at least 75 nucleotides (nt) downstream from the start
codon; the AAG (or AAC) and the following 18nt sequenceJournal of Nucleic Acids 3
Table 1: siRNAs used.
siRNA Sense strand (a),(b) Antisense strand (a),(b) Prevention of UV-TLS
(result)
siRev3-A gcuuuacaugagauacaaaTT uuuguaucucauguaaagcTT signiﬁcant
siRev3-B gacaguuuucagucaagauTT aucuugacugaaaacugucTT signiﬁcant
siRev3-C gagguaugauccugauauuTT aauaucaggaucauaccucTT signiﬁcant
siRev3-D guauugacuuaugucggauTT auccgacauaagucaauacTT signiﬁcant
siRev3cont-A
(6nt mismatches) gguuugaguaauguacgauTT aucguacauuacucaaaccTT no eﬀect
siRev3cont-B
(4nt mismatches) ggauugaguuauguacgauTT aucguacauaacucaauccTT no eﬀect
siRev3cont-C
(2nt mismatches) guauugaguuauguccgauTT aucggacauaacucaauacTT no eﬀect
siRev7-A gauccaggucaucaaggauTT auccuugaugaccuggaucTT partial
siRev7-B gaugcagcuuuacguggaaTT uuccacguaaagcugcaucTT signiﬁcant
siRev7-C cacugucugucucaaauacTT guauuugagacagacagugTT signiﬁcant
siRev7cont-A gaugcagguuuacgucgaaTT uucgacguaaaccugcaucTT no eﬀect
siRev1-A
siRev1-B
siRev1-C
siRev1-D
siRev1cont-E
cacauauuauugccacaaaTT
gaagauugaaacggaaaauTT
ccuucagacugcaauuuuaTT
gugugaauugacugaguuuTT
ccuucacaccgcaacguuaTT
uuuguggcaauaauaugugTT
auuuuccguuucaaucuucTT
uaaaauugcagucugaaggTT
aaacucagucaauucacacTT
uaacguugcggugugaaggTT
signiﬁcant
signiﬁcant
signiﬁcant
signiﬁcant
l i t t l et on oe ﬀect
siPolη-4
siPolη-A
siPolη-B
siPolηcont-A
uaaaccuugugcaguuguaTT
gaaguuauguccagaucuuTT
gcuucgcuuucaucucuuaTT
uaaaccuggugcagucguaTT
uacaacugcacaagguuuaTT
aagaucuggacauaacuucTT
uaagagaugaaagcgaagcTT
uacgacugcaccagguuuaTT
partial
signiﬁcant
signiﬁcant
no eﬀect
siPolι-A
siPolι-5
gccucauacagugagauuaTT
aaguguccacaguugguauTT
uaaucucacuguaugaggcTT
auaccaacuguggacacuuTT
no eﬀect
no eﬀect
siPolκ-A
siPolκ-B
siPolκ-C
siPolκcont-B
gagaaaauuaacaaaauuaTT
gaauaaaccaaauggacaaTT
cuguuaccauuaaguugaaTT
gagaaaaguaacaagcuuaTT
uaauuuuguuaauuuucucTT
uuguccauuugguuuauucTT
uucaacuuaaugguaacagTT
uaagcuuguuacuuuucucTT
partial
partial
considerable
l i t t l et on oe ﬀect
(a)Small letters mean ribonucleotides, and large letters mean deoxyribonucleotides.
(b)Mismatched bases are illustrated in bold and italic letters.
(N18) are picked up. Ideally, the 2nt following the N18 are
TT,TN,NT,orAA.GCcontentofN18isrecommendedtobe
about 40% to 50%. If GC content is less than 30%, or greater
than70%,avoidthesequence.TheN18hadbetterbeAT-rich
in the 3  half and especially at the 3  end (2nt).
2.2. HeLa Cell Culture and siRNA Treatment. HeLa cells were
maintained in monolayers in Dulbecco’s modiﬁed Eagle’s
medium (D’MEM) supplemented with 10% fetal calf serum
(FCS) (“normal” medium), trypsinized and seeded into
culture dishes (2 × 105 cells/φ 60mm dish). About 6–8
hours later, the cells were treated with micelles of siRNA
and OligofectAMINE (Invitrogen), formed according to the
manufacturer’s protocol, except Opti-MEM was replaced
with D’MEM. The siRNA concentration used in RT-PCR
analysis and western blot analysis was 5nM.
2.3. UV Irradiation and Translesion Replication. Forty hours
after siRNA addition, HeLa cells were exposed to UV
light (10J/m2) from a germicidal lamp (Toshiba GL15) at
0.6J/m2 per s. After 30 minutes in culture, the medium was
changed to labeling medium consisting of D’MEM supple-
mented with 10% FCS and 10μCi/mL of [U- 14C]thymidine
(Moravek MC267, 470mCi/mmol). UV-irradiated cells were
pulse-labelled for 1 hour, while nonirradiated cells were
labelled for 30 minutes. The medium was changed to normal
medium, and the cells were chased for 5 hours. These cells
were harvested by trypsinisation and examined by ASDG
[34].
2.4. Alkaline Sucrose Density Gradient Centrifugation
(ASDG). Cells (about 1 × 105 in 50μL PBS) were gently
layered onto 50μL of 1% sucrose in PBS, which was overlaid
on 100μL of lysis solution (0.6MKOH, 2.0M KCl, 10mM
EDTA,and1%N-lauroylsarcosine),whichwasplacedontop
of a 4.35mL alkaline 5–20% sucrose gradient (0.3MKOH,
2.0M KCl, 1mM EDTA, and 0.1% N-lauroylsarcosine) with
0.4mL of alkaline 80% sucrose as a cushion at the bottom.
The gradient was centrifuged at 6,000rpm (4,320 × g)
for 15.6 hours at 15◦C in a Beckman SW 50.1 rotor. The
gradient was fractionated onto 30 circles of no. 17 paper4 Journal of Nucleic Acids
(Whatman). The paper circles were dried, immersed in cold
5% trichloroacetic acid for 10 minutes, washed 3 times with
ethanol and once with acetone, and dried; radioactivity was
then measured. As a molecular weight marker, [14C]-labelled
T4 DNA phage particles were placed on the lysis layer and
sedimented in a parallel run. The approximate fragment
length of each fraction was estimated on the basis of the
position of the T4 DNA marker and that of E. coli DNA and
adjusted by sucrose density curve [34]. Average fragment
length (in megabase(Mb)) of each proﬁle is shown in Figures
as fragment length of the median fraction [35]. (Median
fraction is the middle fraction that separates the higher half
of the proﬁle from the lower half.)
2.5. RT-PCR. Total RNA was isolated using an RNeasy spin
column (QIAGEN). Oneμg of total RNA was treated with
DNase I (Invitrogen), reverse-transcribed using SuperScript
II (Invitrogen) with random hexamers or PrimeScript II
(TaKaRa) with oligo(dT) primers, followed by treatment
with E. coli RNase H (Invitrogen). The PCR mixture
contained cDNA templates, dNTPs, rTaq Pol (TOYOBO),
anti-Taq (TOYOBO), and appropriate primers. Primers to
assess knockdown of each gene were as follows: Rev3,
5 -GGAACGTCAACAGGAGCAAC-3  and 5 -GGAGCA-
AATCCAACACCTGC-3 ;R e v 7 ,5  -TGCTGTCCATCA-
GCTCAGAC-3  and 5 -AGAGCACTTGGAATCAGGGC-
3 ;R e v 1 ,5  -CTCCTGCAGAGAAACCCCTG-3  and 5 -
ACAAGCACTTATGGCACAGCT-3 ;P o l η,5  -CCCAGG-
CAACTACCCAAAAC-3  and 5 -GGGCTCAGTTCCTGT-
ACTTTG-3 ;P o l ι,5  -ATGATCAAGTGTTGCCCACAC-
3  and 5 -ACATGACCCGACACAGTCAC-3 ;P o l κ,5  -
AGACAAGAATACCGCCAGCC-3  and 5 -AGGAAGGAT-
TATTGCACTTGCC-3 ; GAPDH, 5 -ACCACAGTCCAT-
GCCATCAC-3  and 5 -TCCACCACCCTGTTGCTGTA-3 .
A l lP C Rr e a c t i o n sw e r ec a r r i e do u tf o r2 7c y c l e s ,w i t h
the exception of GAPDH (25 cycles). PCR products were
subjected to a MultiNA microtip electrophoresis DNA/RNA
analyzer (Shimadzu Biotech).
2.6. Western Blotting. Cells were rinsed with PBS, lysed with
1 × SDS-PAGE loading buﬀer and collected by scraping.
Cell lysate was boiled for 10 minutes, sonicated for 30
seconds and centrifuged at 20,000 × g for 10 minutes. The
supernatant was used for western blotting after measuring
proteincontentbyBradfordmethod.Thesupernatant(60μg
protein) was separated on 5–20% (Rev7, Rev1 and Polι)
or 3–10% (the rest) SDS-polyacrylamide gels (Wako) and
transferred onto Immobilon-PSQ membranes (Millipore).
The membranes were incubated with antibodies to bypass-
polymerases (Rev1, Santa Cruz Biotechnology sc-48806;
Rev7, BD Transduction Laboratories 612266; Polη,S a n t a
Cruz Biotechnology sc-17770; Polι, Abnova H00011201-
M01;Polκ,akindgiftfromDr.TomooOgi,NagasakiUniver-
sity), and then with horseradish peroxidase-conjugated sec-
ondary antibodies (anti mouse IgG, DAKO PO-0447; anti-
rabit IgG, DAKO PO-0448). Antibodies were diluted with
CanGetSignal (TOYOBO) to enhance immunoreactivity.
The signals were developed with ECL-Plus (GE Healthcare),
and blots were stripped for reprobing with anti α-tubulin
antibody (Sigma T5168).
3. Results
3.1. Eﬀect of siRNAs to Rev3 or Rev7 on HeLa UV-TLS. We
selected 4 target sites from the human Rev3 mRNA sequence
(NCBI locus: NM 002912), according to the JBioS guide.
All the Rev3 siRNAs (Table 1)e ﬀectively knocked down
expression of Rev3 (Figure 1(a)) and, at 5nM, abolished
UV-TLS in HeLa cells (Figure 1(b)). Replication products
immediately after UV irradiation were sedimented as a
sharp peak, illustrated by a thin line in Figure 1(b), slightly
larger in size than the T4 phage DNA marker. When only
Oligofectamine-treated cells were chased in normal medium
for 5 hours, the products joined to form larger DNA with
lengths in the order of megabases (Mb), illustrated by a thick
line. In Rev3 siRNA-transfected cells, the products remain
in smaller size, as depicted by a thin line with open marks,
demonstrating these siRNAs prevent UV-TLS (Figure 1(b)).
We assessed how many mismatched nucleotides (nt)
are necessary at minimum for the negative control siRNA
(Figure 1(c)) and found that siRev3cont-C, designed from
siRev3-D with 2nt mismatches, did not prevent UV-TLS,
indicating that these Rev3 siRNAs degrade Rev3 mRNA
with high speciﬁcity. The dose-response proﬁle of siRev3-D,
shows that only 1nM siRNA suﬃciently inhibited UV-TLS
(Figure 1(d)) .T h es i R e v 3 - Ds i R N Ah a dn oe ﬀect on normal
replication (Figure 1(e)).
We selected 3 target sites from the human Rev7
mRNA sequence (NM 006341) (Table 1), and found that
all siRNAs eﬀectively reduced Rev7 expression (Figure 2(a));
5nM siRev7-B or siRev7-C completely abolished UV-TLS
(siRev7-Aelicitedonlypartialprevention)(Figure 2(b)).The
siRev7cont-A,designedfromsiRev7-Bwith2ntmismatches,
had no eﬀect (ibid). The dose-response proﬁle of siRev7-
B shows that 1nM siRNA was suﬃcient to inhibit UV-
TLS (Figure 2(c)); Rev7 siRNAs had no eﬀect on normal
replication (Figure 2(d)).
3.2. SiRNAs to Rev1 Signiﬁcantly Abrogated UV-TLS. For
knockdown of Rev1 expression, we selected 4 sites from
the human Rev1 mRNA sequence (NM 016316) (Table 1)
(Figure 3(a)).ThesiRNAs(5nM)targetedtothesesitesabol-
ished UV-TLS in HeLa cells (Figure 3(b)). The siRev1cont-
E, designed from siRev1-C with 4nt mismatches, had little
to no eﬀect. The dose-response proﬁle of siRev1-C shows
that 1nM of the siRNA was enough to inhibit UV-TLS
(Figure 3(c)); siRev1-C or siRev1-D siRNA had no eﬀect on
normal replication (Figure 3(d)).
3.3. SiRNAs to Polη Prevented UV-TLS to a Great Extent.
First,wetestedthesiRNAdescribedbyChoiandPfeifer[37],
siPolη-4, which partially inhibited UV-TLS (Figure 4(a)).
T h en e g a t i v ec o n t r o l ,s i P o l ηcont-A, was designed from
siPolη-4with2ntmismatches,hadnoeﬀect(ibid).Weadded
2P o l η siRNAs of new design (human Polη mRNA sequence:
NM 006502) (Table 1), and these siRNAs also eﬀectivelyJournal of Nucleic Acids 5
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Figure 1: Eﬃcient knockdown by Rev3 siRNAs and their eﬀects on UV-induced TLS in HeLa cells (ASDG proﬁles of replication products).
(a) Eﬃciency of knockdown on Rev3 expression (RT-PCR analysis); (b) Eﬀects of various Rev3 siRNAs; (c) Eﬀects of Rev3 control siRNAs;
(d) Dose-response of siRev3-D; (e) Eﬀect of various Rev3 siRNAs (no UV control). Twenty-four hours after Rev3 siRNA transfection,
total RNA was isolated and Rev3 RNA was quantiﬁed by RT-PCR. Results were shown in MultiNA gel images and the expression level was
presented under the panel (a). Forty hours after Rev3 siRNA transfection, cells were UV-irradiated (10J/m2), incubated in normal medium
for 30 minutes, pulse-labelled with 10μCi/mL of [14C]thymidine for 1 hour, washed twice with PBS, and incubated for 5 hours at 37◦Ci n
normal medium (b, c, d). siRev3cont-A, 6nt mismatches; siRev3cont-B, 4nt mismatches; siRev3cont-C, 2nt mismatches (c). Forty hours
after Rev3 siRNA transfection, cells were not UV-irradiated, pulse-labelled with 10μCi/mL of [14C]thymidine for 30 minutes, washed twice
with PBS, and incubated at 37◦C in normal medium for 1 hour (e). Some of these proﬁles overlap (c, d, e). Sedimentation is from right
to left. The arrow indicates the position of T4 phage DNA (166 kb, i.e., approximately 5.5 × 107 Da/single strand). Labelled E.coli DNA
(approximately 4Mb) sedimented near the bottom (fractions 3–6) (4). Average fragment length (in Mb) of each proﬁle is shown in square
brackets as fragment length of the median fraction.6 Journal of Nucleic Acids
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Figure 2: Eﬃcient knockdown by Rev7 siRNAs and their eﬀects on UV-induced TLS in HeLa cells (ASDG proﬁles of replication products).
(a) Eﬃciency of knockdown on Rev7 expression (RT-PCR analysis and western blot analysis); (b) Eﬀects of various Rev7 siRNAs; (c) Dose-
response of siRev7-B; (d) Eﬀect of various Rev7 siRNAs (no UV control). Twenty-four hours after Rev7 siRNA transfection, total RNA was
isolated and Rev7 RNA was quantiﬁed by RT-PCR. Results were shown in MultiNA gel images and the expression level was presented under
the panel (a). Forty hours after Rev7 siRNA transfection, whole cell extracts were prepared and Rev7 protein was quantiﬁed by western blot
analysis (a). Forty hours after Rev7 siRNA transfection, cells were UV-irradiated (10J/m2), incubated in normal medium for 30 minutes,
pulse-labelledwith10μCi/mLof[14C]thymidinefor1hour,washedtwicewithPBS,andincubatedfor5hoursat37◦Cinnormalmedium(b ,
c).Forty hours after Rev7 siRNAtransfection, cells were notUV-irradiated, pulse-labelled with 10μCi/mL of [14C]thymidine for 30 minutes,
washedtwicewithPBS,andincubatedat37◦Cinnormalmediumfor1hour(d).Someoftheseproﬁlesoverlap(c,d).Sedimentationisfrom
right to left. The arrow indicates the position of T4 phage DNA (166kb, i.e., approximately 5.5 × 107 Da/single strand). Average fragment
length (in Mb) of each proﬁle is shown in square brackets.
knocked down Polη expression (Figure 4(b)). These latter
siRNAs at 5nM abolished UV-TLS to a greater extent than
siPolη-4 (Figure 4(c)). The Polη siRNAs had no eﬀect on
normal replication (Figure 4(d)).
3.4. Polκ siRNAs Delayed UV-TLS, While siRNAs to Polι
Did Not. Although Polι siRNAs eﬃciently prevented Polι
expression (Figure 5(a)), we could not detect these eﬀects on
ASDG proﬁles (Figure 5(b)). The siPolι-5 was reported byJournal of Nucleic Acids 7
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Figure 3: Eﬃcient knockdown by Rev1 siRNAs and their eﬀects on UV-induced TLS in HeLa cells (ASDG proﬁles of replication products).
(a)EﬃciencyofknockdownonRev1expression(RT-PCRanalysisandwesternblotanalysis);(b)EﬀectsofvariousR ev1siRN A sonUV -TLS;
(c) Dose-response of siRev1-C on UV-TLS; (d) Eﬀect of various siRNAs (no UV control). Twenty-four hours after Rev1 siRNA transfection,
total RNA was isolated and Rev1 RNA was quantiﬁed by RT-PCR. Results were shown in MultiNA gel images and the expression level
was presented under the panel (a). Forty hours after Rev1 siRNA transfection, whole cell extracts were prepared and Rev1 protein was
quantiﬁed by western blot analysis (a). Forty hours after Rev1 siRNA transfection, cells were UV-irradiated (10J/m2), incubated in normal
medium for 30 minutes, pulse-labelled with 10μCi/mL of [14C]thymidine for 1 hour, then washed twice with PBS, and incubated for
5h o u r sa t3 7 ◦C in normal medium (b, c). Forty hours after Rev1 siRNA transfection, cells were not UV-irradiated, pulse-labelled with
10μCi/mL of [14C]thymidine for 30 minutes, washed twice with PBS, and incubated at 37◦C in normal medium for 1 hour (d). Some of
theseproﬁlesoverlap(b,c).Sedimentationisfromrighttoleft.ThearrowindicatesthepositionofT4phageDNA(166kb,i.e.,approximately
5.5 ×107 Da/single strand). Average fragment length (in Mb) of each proﬁle is shown in square brackets.
Choi et al. [38], and the target sequence of siPolι-A was 4nt
downstream from the one reported by Machida et al. [39]
(human Polι mRNA sequence: NM 007195).
We prepared 3 siRNAs for knockdown of Polκ mRNA
(NM 016218) (Figure 6(a)). In contrast to siPolι, these
Polκ siRNAs (5nM) delayed UV-TLS in HeLa cells
(Figure 6(b)). The siPolκcont-B, from siPolκ-A with
3nt mismatches, had little to no eﬀect. The dose-
response proﬁle of siPolκ-A shows that the molecule
suﬃciently inhibited UV-TLS at 1nM (Figure 6(c)).
The Polκ siRNAs had no eﬀect on normal replication
(Figure 6(d)).8 Journal of Nucleic Acids
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Figure 4: Eﬃcient knockdown by Polη siRNAs and the eﬀects on UV-induced TLS in HeLa cells (ASDG proﬁles of replication products).
(a) Dose-response of siPolη-4 on UV-TLS, Eﬃciency of knockdown on Polη expression; (b) RT-PCR analysis and western blot analysis,
(c) Eﬀects of various Polη siRNAs on UV-TLS, (d) Eﬀect of various Polη siRNAs (no UV control). Twenty-four hours after Polη siRNA
transfection,totalRNAwas isolatedandPolη RNAwas quantiﬁed byRT-PCR.Resultswere showninMultiNAgel images and theexpression
level was presented under the panel (b). Forty hours after Polη siRNA transfection, whole cell extracts were prepared and Polη protein was
quantiﬁed by western blot analysis (b). Forty hours after Polη siRNA transfection, cells were UV-irradiated (10J/m2), incubated in normal
medium for 30 minutes, pulse-labelled with 10μCi/mL of [14C]thymidine for 1 hour, then washed twice with PBS, and incubated for
5h o u r sa t3 7 ◦C in normal medium (a, c). Forty hours after Polη siRNA transfection, cells were not UV-irradiated, pulse-labelled with
10μCi/mL of [14C]thymidine for 30 minutes, washed twice with PBS, and incubated at 37◦C in normal medium for 1 hour (d). Some of
these proﬁles overlap (d). Sedimentation is from right to left. The arrow indicates the position of T4 phage DNA (166kb, i.e., approximately
5.5 ×107 Da/single strand). Average fragment length (in Mb) of each proﬁle is shown in square brackets.
4. Discussion
We veriﬁed the involvement of multiple bypass polymerases
in UV-TLS in HeLa cells using original siRNAs and ASDG
technique, which is consistent with the recent model of 2
polymerase mechanisms [40, 41]. Rev3 and Rev7, which
comprise Polζ, were conﬁrmed to participate in mutagenic
UV-TLS. Also, Rev1 was suggested to play an important roleJournal of Nucleic Acids 9
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Figure 5: Eﬃcient knockdown by Polι siRNAs and the eﬀects on UV-induced TLS in HeLa cells (ASDG proﬁles of replication products). (a)
Eﬃciency of knockdown on Polι expression (RT-PCR analysis and western blot analysis); (b) Eﬀects of two Polι siRNAs on UV-TLS. Twenty-
four hours after Polι siRNA transfection, total RNA was isolated and Polι RNA was quantiﬁed by RT-PCR. Results were shown in MultiNA
gel images and the expression level was presented under the panel (a). Forty hours after Polι siRNA transfection, whole cell extracts were
prepared and Polι protein was quantiﬁed by western blot analysis (a). Forty hours after Polι siRNA transfection, cells were UV-irradiated
(10J/m2), incubated in normal medium for 30 minutes, pulse-labelled with 10μCi/mL of [14C]thymidine for 1 hour, then washed twice
with PBS, and incubated for 5 hours at 37◦C in normal medium (b). Sedimentation is from right to left. The arrow indicates the position of
T4 phage DNA (166kb, i.e., approximately 5.5 × 107 Da/single strand). Average fragment length (in Mb) of each proﬁle is shown in square
brackets.
in human TLS, although in avian DT40 cells, Rev1 may have
a distinct role [42]. We were surprised to ﬁnd that siRNAs
againstPolη preventedTLStoagreatextent.TLSwasdelayed
in Polκ siRNA-transfected cells, but not in siPolι-transfected
cells.
We anticipated a limited participation of Polη,b e c a u s e
UV-TLS in HeLa cells is very slow (i.e., ineﬃcient) and
caﬀeine-sensitive[35].However,siRNAsagainstPolη,partic-
ularlysiPolη-AandsiPolη-B, prevented TLS to a great extent.
SincebothRev3andRev7siRNAsalsosigniﬁcantlyabolished
UV-TLS, these results suggest that the Polζ-dependent TLS
pathway and the Polη-dependent process are not mutually
exclusive but overlapped.
Enzymology of yeast Polζ revealed that this polymerase
is too faithful to insert nucleotides opposite a CPD, although
it eﬃciently extends from a matched or mismatched 3 
end [5, 6]. Therefore, we assumed that mutagenic (error-
prone) TLS proceeded through the insertion by Polι or
PolκofmismatchednucleotidesoppositeUVphotoproducts,
followed by extension by Polζ. Our data showed, however,
that siPolι had no eﬀect, and siPolκ partially prevented TLS.
These results suggest that in some cases, Polη,a n dt oa
lesser extent Polκ, may insert nucleotide(s) opposite UV
photoproducts, followed by extension by Polζ.
Polη is capable of bypassing a CPD without aid of other
TLS polymerases. Both yeast and human Polη,h o w e v e r ,
incorporate wrong nucleotide at a fairly high rate and can
extend these mismatched primer termini with only a fre-
quency of ∼10−2 to 10
−3 relative to extension from matched
primer termini [6, 43]. Plausibly, Polη dissociates from
there and the proof-reading exonuclease of Polδ removes
the wrong nucleotide [44]. To the primer termini, Polη is
recruitedagainandincorporatesanewnucleotide.Thiscycle
is repeated until Polη incorporates a correct nucleotide. We
suppose that disruption or malfunction of this cooperation
renders mismatched primer termini accessible to Polζ.
Recently, Yoon et al. published 2 papers describing the
eﬀects of siRNA knockdown on the eﬃciency of TLS at TT-
CPD [45] or (6-4)TT PP [46] on duplex plasmids in human
cells. They also reported the eﬀects of siRNA knockdown on
mutation frequencies in the λ phage cII gene lysogenized in
mouse cells expressing a (6-4)PP photolyase [45]o rC P D
photolyase [46]. The results of this tremendous and detailed
study demonstrated that Pols η, κ,a n dζ contribute to
CPD bypass, wherein Pols κ and ζ promote mutagenic TLS
and Polη executes error-free bypasses (Polι siRNA had no
eﬀect) [45]. As for (6-4)PP bypass, Pols η and ι provide
alternate pathways for mutagenic TLS, and Polζ acts in a
predominantlyerror-freemanner(PolκsiRNAhadnoeﬀect)
[46].
The participation of Pols κ or ι in CPD bypass was
similarly demonstrated by our results and those of Yoon et
al. [45]. Because (6-4)PP is a minor photoproduct, which
is removed predominantly by NER, and because HeLa cells10 Journal of Nucleic Acids
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Figure 6: Eﬃcient knockdown by Polκ siRNAs and the eﬀects on UV-induced TLS in HeLa cells (ASDG proﬁles of replication products).
(a) Eﬃciency of knockdown on Polκ expression (RT-PCR analysis and western blot analysis), (b) Eﬀects of various Polκ siRNAs on UV-
TLS, (c) Dose-response of siPolκ-A on UV-TLS, (d) Eﬀect of various Polκ siRNAs (no UV control). Twenty-four hours after Polκ siRNA
transfection, total RNA was isolated and Polκ RNA was quantiﬁed by RT-PCR.Results were shown in MultiNA gel images and the expression
level was presented under the panel (a). Forty hours after Polκ siRNA transfection, whole cell extracts were prepared, and Polκ protein
was quantiﬁed by western blot analysis (a). Forty hours after Polκ siRNA transfection, cells were UV-irradiated (10J/m2), incubated in
normal medium for 30 minutes, pulse-labelled with 10μCi/mL of [14C]thymidine for 1 hour, then washed twice with PBS, and incubated
for 5 hours at 37◦C in normal medium (b, c). Forty hours after Polκ siRNA transfection, cells were not UV-irradiated, pulse-labelled with
10μCi/mLof [14C]thymidinefor30minutes,washedtwicewithPBS,andincubatedat37◦Cinnormalmediumfor1hour(d).Someofthese
proﬁles overlap (c, d). Sedimentation is from right to left. The arrow indicates the position of T4 phage DNA (166kb, i.e., approximately
5.5 ×107 Da/single strand). Average fragment length (in Mb) of each proﬁle is shown in square brackets.
possess high NER activity (unpublished observation), it is
reasonable to conclude that our phenomena observed in
HeLacellsbyASDGarelargelyattributabletoCPD,although
we have not yet determined the extent of remaining (6-4)PP.
We may also conclude that Rev1 is indispensable for
TLS across CPD. Thus far, it is unknown if Rev1 is equally
involved in TLS across CPD and (6-4)PP, or if it exhibits
some preference. Nelson et al. [25] demonstrated that
Rev1p participates in UV-TLS across (6-4)PP, based on yeast
transfected with a (6-4)PP-carrying plasmid; only slight
diﬀerences were observed with a CPD-carrying plasmid.
In vitro lesion-bypass assay showed that Polη alone
a c c o m p l i s h e sb y p a s sa c r o s sT T - C P Da sa b o v e( i . e . ,b o t h
insertion and extension) [8, 9]. However, Yoon et al.Journal of Nucleic Acids 11
presented complex results showing involvement of multiple
bypass polymerases. They used SV-untransformed XP-A
and XP-V cells, but did not include SV-untransformed
normal ﬁbroblasts, wherein we detected quick and caﬀeine-
insensitive UV-TLS [35, 36]. It is possible that the kind
of damage, as well as cell status (normal, transformed,
or cancerous) may determine the participation of bypass
polymerase(s).
We have presented the ﬁrst apparent evidence that Polκ
participates in UV-TLS. Polκ knockout mouse embryonic
cells are known to be UV sensitive [47], but the mechanism
had not yet been determined. Polκ is also thought to play a
part in the repair-synthesis step of NER [48, 49]. From the
results of lesion-bypass assays, human Polκ was suggested to
beunabletobypassCPDor(6-4)PP.Becausetheoutcomesof
suchinvitroassaysdependontheassayconditions[12],these
results must be validated in vivo,s u c ha sb yA S D Ga n a l y s i s .
5. Conclusions
Using siRNAs originally designed and ASDG technique, we
veriﬁed the participation of multiple bypass polymerases in
UV-induced TLS in HeLa cells, which is the consistent with
recent model of 2 polymerase mechanisms. UV-TLS was
largely abolished by siRNAs to Rev3 or Rev7, suggesting that
these 2 proteins, which constitute Polζ, play a primary role
in mutagenic TLS. Rev1-targeted siRNAs also signiﬁcantly
abolished UV-TLS, consistent with prior suggestions that
Rev1 is indispensable in mammalian mutagenic TLS. Unex-
pectedly, siRNAs to Polη prevented TLS to a great extent,
implying that the Polη-a n dP o l ζ-dependent processes do
not alternate but overlap. Polκ siRNAs, but not siRNAs to
Polι, delayed TLS; this is the ﬁrst apparent evidence for the
participation of Polκ in UV-TLS.
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